The MN1-TEL fusion protein, encoded by the translocation (12;22)(p13;q11) in myeloid leukemia, is a transcription factor with transforming activity

Molecular and Cellular Biology

Volumn 20, Issue 24, 2000, Pages 9281-9293

  Buijs, A ^a   Van Rompaey, L ^a   Molijn, A C ^a   Davis, J N ^a   Vertegaal, A C O ^a   Potter, M D ^a   Adams, C ^a   Van Baal, S ^a   Zwarthoff, E C ^a   Roussel, M F ^a   Grosveld, G C ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERIC PROTEIN; HYBRID PROTEIN; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL CELL; ARTICLE; CHROMOSOME 12P; CHROMOSOME 22Q; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 22; CONTROLLED STUDY; LEUKEMOGENESIS; MALIGNANT TRANSFORMATION; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; CLONING, MOLECULAR; DNA; DNA-BINDING PROTEINS; GENES, REGULATOR; HUMANS; IMMUNOBLOTTING; LEUKEMIA, MYELOID; MICE; MICROSCOPY, CONFOCAL; ONCOGENE PROTEINS, FUSION; PRECIPITIN TESTS; PROMOTER REGIONS (GENETICS); PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-ETS; REPRESSOR PROTEINS; RETROVIRIDAE; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TRANSFECTION; TRANSLOCATION, GENETIC;

ANIMALIA; MOLONEY MURINE SARCOMA VIRUS;

EID: 0034461081     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.24.9281-9293.2000     Document Type: Article

References (52)

1. DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma
2. Mechanism for transcriptional gain of function resulting from chromosomal translocation in alveolar rhabdomyosarcoma
3. Definition of an Ets1 protein domain required for nuclear localization in cells and DNA-binding activity in vitro
4. Translocation (12;22)(p13;q11) in myeloproliferative disorders results in fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11
5. The TEL/platelet-derived growth factor β receptor (PDGFβR) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGFβR kinase-dependent signaling pathways
6. TEL-JAK2 transgenic mice develop T-cell leukemia
7. The tyrosine kinase ab1-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): Molecular cloning of both reciprocal transcripts
8. The leukemia-associated gene TEL encodes a transcription repressor which associates with SMRT and mSIN3A
9. Fusion of ETV6 to the caudal-related homeobox gene CDX2 in acute myeloid leukemia with the t(12;13)(p13;q12)
10. Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with t(4;12)(q11-q12;p13)
11. DNA sequence of the herpes simplex virus type 1 gene whose product is responsible for transcriptional activation of immediate early promoters
12. Fusion of ETV6 to neurotrophin-5 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25)
13. Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein
14. Relocation of the carboxyterminal part of CAN from the nuclear envelope to the nucleus as a result of leukemia-specific chromosome rearrangements
15. Interaction of cellular proteins with the leukemia specific fusion proteins DEK-CAN and SET-CAN and their normal counterpart, the nucleoporin CAN
16. Transcriptional activation modulated by homopolymeric glutamine and proline stretches
17. Assembly and function of a TCRα enhancer complex is dependent on LEF-1-induced DNA bending and multiple protein-protein interactions
18. A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation
19. Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia
20. Fusion of PDGF receptor β to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation
21. Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia
22. Sequence-specific DNA binding of the proto-oncoprotein ETS-1 defines a transcriptional activator sequence within the long terminal repeat of the Moloney murine sarcoma virus
23. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6
24. A domain of TEL conserved in a subset of ETS proteins defines a specific oligomerization interface essential to the mitogenic properties of the TEL-PDGFRβ onco-protein
25. The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials
26. A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma
27. A new pattern for helix-turn-helix recognition revealed by the PU.1 ETS-domain-DNA complex
28. The scanning model for translation: An update
29. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
30. The oncogenic potential of the Pax3-FKHR fusion protein requires the Pax3 homeodomain recognition helix but not the Pax3 paired-box DNA binding domain
31. Cloning and characterization of MN1, a gene from chromosome 22q11, which is disrupted by a balanced translocation in a meningioma
32. Multiple domains mediate transformation by the Ewing's sarcoma EWS-FLI-1 fusion gene
33. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia
34. TEL is a sequence-specific transcriptional repressor
35. The BCR-ABL oncogene transforms Rat-1 cells and cooperates with v-myc
36. Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation
37. The Ewing's sarcoma EWS/FLI-1 fusion gene encodes a more potent transcriptional activator and is a more powerful transforming gene than FLI-1
38. BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias
39. RAS oncogene activation of a VL30 transcriptional element is linked to transformation
40. The novel activation of ABL by fusion to an ets-related gene
41. Fusion of TEL, the ETS variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;12;15) in a myeloid leukemia
42. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases
43. The TEL gene products: Nuclear phosphoproteins with DNA binding properties
44. The t(12;21) of acute lymphoblastic leukemia results in a TEL-AML1 gene fusion
45. The role of chromosome translocations in leukemogenesis
46. A family of octamer-specific proteins present during mouse embryogenesis: Evidence for germline-specific expression of an Oct factor
47. Characterization of the chronic myelomonocytic leukemia associated TEL-PDGFβR fusion protein
48. Incorporation of glutamine repeats makes protein oligomerize: Implications for neurode-generative diseases
49. DNA binding specificity studies of four ETS proteins support an indirect read-out mechanism of protein-DNA recognition
50. TEL/PDGFβR induces hematologic malignancies in mice that respond to a specific tyrosine kinase inhibitor
51. Tel, a frequent target of leukemic translocations, induces cellular aggregation and influences expression of extracellular matrix components
52. The Ets family of transcription factors